nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ABCC2—chronic kidney failure	0.345	0.456	CbGaD
Canagliflozin—CYP3A4—chronic kidney failure	0.153	0.201	CbGaD
Canagliflozin—ALB—chronic kidney failure	0.133	0.176	CbGaD
Canagliflozin—ABCB1—chronic kidney failure	0.127	0.168	CbGaD
Canagliflozin—SLC5A2—nephron—chronic kidney failure	0.0188	0.204	CbGeAlD
Canagliflozin—SLC5A2—urine—chronic kidney failure	0.0151	0.164	CbGeAlD
Canagliflozin—SLC5A2—blood plasma—chronic kidney failure	0.00789	0.0854	CbGeAlD
Canagliflozin—SLC5A2—nephron tubule—chronic kidney failure	0.00407	0.044	CbGeAlD
Canagliflozin—SLC5A2—renal system—chronic kidney failure	0.0037	0.04	CbGeAlD
Canagliflozin—SLC5A2—kidney—chronic kidney failure	0.00358	0.0387	CbGeAlD
Canagliflozin—SLC5A2—cortex of kidney—chronic kidney failure	0.00348	0.0377	CbGeAlD
Canagliflozin—SLC5A1—nephron tubule—chronic kidney failure	0.00308	0.0334	CbGeAlD
Canagliflozin—SLC5A2—blood—chronic kidney failure	0.00289	0.0313	CbGeAlD
Canagliflozin—SLC5A1—renal system—chronic kidney failure	0.0028	0.0303	CbGeAlD
Canagliflozin—SLC5A1—cardiovascular system—chronic kidney failure	0.00277	0.03	CbGeAlD
Canagliflozin—SLC5A1—kidney—chronic kidney failure	0.00271	0.0293	CbGeAlD
Canagliflozin—UGT2B4—cardiovascular system—chronic kidney failure	0.00255	0.0276	CbGeAlD
Canagliflozin—Dapagliflozin—CYP1A1—chronic kidney failure	0.00239	0.461	CrCbGaD
Canagliflozin—SLC5A1—digestive system—chronic kidney failure	0.0023	0.0249	CbGeAlD
Canagliflozin—UGT1A9—renal system—chronic kidney failure	0.00176	0.0191	CbGeAlD
Canagliflozin—UGT1A9—kidney—chronic kidney failure	0.00171	0.0185	CbGeAlD
Canagliflozin—CYP3A4—urine—chronic kidney failure	0.00158	0.0171	CbGeAlD
Canagliflozin—Dapagliflozin—CYP3A4—chronic kidney failure	0.00152	0.294	CrCbGaD
Canagliflozin—UGT1A9—digestive system—chronic kidney failure	0.00145	0.0157	CbGeAlD
Canagliflozin—Dapagliflozin—ABCB1—chronic kidney failure	0.00127	0.245	CrCbGaD
Canagliflozin—ABCC2—nephron tubule—chronic kidney failure	0.000839	0.00908	CbGeAlD
Canagliflozin—CYP3A4—blood plasma—chronic kidney failure	0.000826	0.00894	CbGeAlD
Canagliflozin—ABCC2—renal system—chronic kidney failure	0.000763	0.00825	CbGeAlD
Canagliflozin—ABCC2—kidney—chronic kidney failure	0.000737	0.00798	CbGeAlD
Canagliflozin—ORM1—blood—chronic kidney failure	0.000725	0.00785	CbGeAlD
Canagliflozin—ABCC2—cortex of kidney—chronic kidney failure	0.000718	0.00777	CbGeAlD
Canagliflozin—ABCC2—digestive system—chronic kidney failure	0.000626	0.00677	CbGeAlD
Canagliflozin—ABCC2—blood—chronic kidney failure	0.000596	0.00645	CbGeAlD
Canagliflozin—ABCB1—blood plasma—chronic kidney failure	0.000585	0.00633	CbGeAlD
Canagliflozin—CYP3A4—renal system—chronic kidney failure	0.000387	0.00419	CbGeAlD
Canagliflozin—CYP3A4—kidney—chronic kidney failure	0.000375	0.00405	CbGeAlD
Canagliflozin—CYP3A4—digestive system—chronic kidney failure	0.000318	0.00344	CbGeAlD
Canagliflozin—CYP3A4—blood—chronic kidney failure	0.000303	0.00328	CbGeAlD
Canagliflozin—ABCB1—nephron tubule—chronic kidney failure	0.000302	0.00327	CbGeAlD
Canagliflozin—ABCB1—renal system—chronic kidney failure	0.000274	0.00297	CbGeAlD
Canagliflozin—ABCB1—cardiovascular system—chronic kidney failure	0.000271	0.00293	CbGeAlD
Canagliflozin—ABCB1—urethra—chronic kidney failure	0.000269	0.00292	CbGeAlD
Canagliflozin—ABCB1—kidney—chronic kidney failure	0.000265	0.00287	CbGeAlD
Canagliflozin—ABCB1—cortex of kidney—chronic kidney failure	0.000258	0.00279	CbGeAlD
Canagliflozin—ABCB1—gonad—chronic kidney failure	0.000246	0.00266	CbGeAlD
Canagliflozin—ABCB1—digestive system—chronic kidney failure	0.000225	0.00243	CbGeAlD
Canagliflozin—ABCB1—blood—chronic kidney failure	0.000214	0.00232	CbGeAlD
Canagliflozin—UGT1A9—Metabolism—LCAT—chronic kidney failure	4.07e-05	0.000282	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—VEGFA—chronic kidney failure	4.06e-05	0.000282	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—chronic kidney failure	4.06e-05	0.000282	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—chronic kidney failure	4.03e-05	0.000279	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—POMC—chronic kidney failure	4.01e-05	0.000278	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—POMC—chronic kidney failure	4.01e-05	0.000278	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	3.99e-05	0.000277	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	3.94e-05	0.000273	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	3.91e-05	0.000271	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic kidney failure	3.87e-05	0.000268	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MTHFR—chronic kidney failure	3.87e-05	0.000268	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	3.86e-05	0.000267	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—chronic kidney failure	3.82e-05	0.000265	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—chronic kidney failure	3.82e-05	0.000265	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARA—chronic kidney failure	3.8e-05	0.000263	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—AVP—chronic kidney failure	3.79e-05	0.000263	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	3.77e-05	0.000262	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DDC—chronic kidney failure	3.74e-05	0.000259	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—TGFB1—chronic kidney failure	3.73e-05	0.000259	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	3.7e-05	0.000256	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	3.67e-05	0.000254	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—GCKR—chronic kidney failure	3.67e-05	0.000254	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ALB—chronic kidney failure	3.65e-05	0.000253	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ALB—chronic kidney failure	3.65e-05	0.000253	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PRKD1—chronic kidney failure	3.63e-05	0.000251	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2B6—chronic kidney failure	3.63e-05	0.000251	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PRKAG2—chronic kidney failure	3.63e-05	0.000251	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—VEGFA—chronic kidney failure	3.6e-05	0.000249	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.59e-05	0.000249	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	3.57e-05	0.000248	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	3.56e-05	0.000247	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic kidney failure	3.55e-05	0.000246	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	3.52e-05	0.000244	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NOS3—chronic kidney failure	3.49e-05	0.000242	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NOS3—chronic kidney failure	3.49e-05	0.000242	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	3.48e-05	0.000241	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	3.45e-05	0.000239	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SREBF2—chronic kidney failure	3.4e-05	0.000235	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FABP1—chronic kidney failure	3.31e-05	0.000229	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TGFB1—chronic kidney failure	3.3e-05	0.000229	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GCKR—chronic kidney failure	3.28e-05	0.000227	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCC3—chronic kidney failure	3.28e-05	0.000227	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—chronic kidney failure	3.28e-05	0.000227	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—chronic kidney failure	3.23e-05	0.000224	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	3.21e-05	0.000223	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	3.21e-05	0.000223	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LPIN1—chronic kidney failure	3.21e-05	0.000223	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—chronic kidney failure	3.2e-05	0.000222	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—chronic kidney failure	3.2e-05	0.000222	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	3.15e-05	0.000219	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—F2—chronic kidney failure	3.15e-05	0.000218	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LRP2—chronic kidney failure	3.14e-05	0.000218	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2C18—chronic kidney failure	3.14e-05	0.000218	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	3.14e-05	0.000218	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GATM—chronic kidney failure	3.13e-05	0.000217	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AGXT—chronic kidney failure	3.13e-05	0.000217	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—POMC—chronic kidney failure	3.09e-05	0.000214	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—chronic kidney failure	3.08e-05	0.000214	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	3.08e-05	0.000214	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	3.06e-05	0.000212	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	3.06e-05	0.000212	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.93e-05	0.000203	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FABP1—chronic kidney failure	2.9e-05	0.000201	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ACAT1—chronic kidney failure	2.87e-05	0.000199	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.83e-05	0.000196	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—chronic kidney failure	2.82e-05	0.000196	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.8e-05	0.000194	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF1—chronic kidney failure	2.76e-05	0.000191	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFB1—chronic kidney failure	2.76e-05	0.000191	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFB1—chronic kidney failure	2.76e-05	0.000191	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.75e-05	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AGXT—chronic kidney failure	2.75e-05	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GATM—chronic kidney failure	2.75e-05	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	2.72e-05	0.000188	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NOS3—chronic kidney failure	2.7e-05	0.000187	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS1—chronic kidney failure	2.69e-05	0.000186	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CPT1A—chronic kidney failure	2.67e-05	0.000185	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.67e-05	0.000185	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MLXIPL—chronic kidney failure	2.67e-05	0.000185	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic kidney failure	2.62e-05	0.000182	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.62e-05	0.000181	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LIPC—chronic kidney failure	2.61e-05	0.000181	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2C19—chronic kidney failure	2.61e-05	0.000181	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—chronic kidney failure	2.6e-05	0.000181	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.57e-05	0.000178	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—KRAS—chronic kidney failure	2.56e-05	0.000177	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—KRAS—chronic kidney failure	2.56e-05	0.000177	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	2.54e-05	0.000176	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ACAT1—chronic kidney failure	2.51e-05	0.000174	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	2.5e-05	0.000174	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—chronic kidney failure	2.47e-05	0.000171	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC22A2—chronic kidney failure	2.44e-05	0.000169	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SCARB1—chronic kidney failure	2.41e-05	0.000167	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS1—chronic kidney failure	2.38e-05	0.000165	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.38e-05	0.000165	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.34e-05	0.000162	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SREBF1—chronic kidney failure	2.34e-05	0.000162	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MLXIPL—chronic kidney failure	2.34e-05	0.000162	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HMGCR—chronic kidney failure	2.27e-05	0.000158	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCG1—chronic kidney failure	2.27e-05	0.000157	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	2.25e-05	0.000156	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—FASN—chronic kidney failure	2.22e-05	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIP5K1B—chronic kidney failure	2.22e-05	0.000154	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.17e-05	0.000151	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ARG2—chronic kidney failure	2.17e-05	0.000151	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC22A2—chronic kidney failure	2.14e-05	0.000148	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LCAT—chronic kidney failure	2.13e-05	0.000148	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—chronic kidney failure	2.08e-05	0.000144	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—chronic kidney failure	2.08e-05	0.000144	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP3A4—chronic kidney failure	2.06e-05	0.000143	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.05e-05	0.000142	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCA1—chronic kidney failure	2.03e-05	0.00014	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCG1—chronic kidney failure	1.99e-05	0.000138	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DDC—chronic kidney failure	1.96e-05	0.000136	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	1.96e-05	0.000136	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	1.94e-05	0.000135	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AVP—chronic kidney failure	1.93e-05	0.000134	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ARG2—chronic kidney failure	1.9e-05	0.000132	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PRKAG2—chronic kidney failure	1.9e-05	0.000132	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2B6—chronic kidney failure	1.9e-05	0.000132	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PRKD1—chronic kidney failure	1.9e-05	0.000132	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—POMC—chronic kidney failure	1.89e-05	0.000131	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.87e-05	0.00013	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LCAT—chronic kidney failure	1.87e-05	0.000129	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	1.87e-05	0.000129	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.81e-05	0.000125	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	1.8e-05	0.000125	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FABP1—chronic kidney failure	1.78e-05	0.000124	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SREBF2—chronic kidney failure	1.78e-05	0.000123	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	1.77e-05	0.000123	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PLAU—chronic kidney failure	1.75e-05	0.000121	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCKR—chronic kidney failure	1.72e-05	0.000119	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCC3—chronic kidney failure	1.72e-05	0.000119	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAT—chronic kidney failure	1.72e-05	0.000119	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DDC—chronic kidney failure	1.71e-05	0.000119	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GATM—chronic kidney failure	1.69e-05	0.000117	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AGXT—chronic kidney failure	1.69e-05	0.000117	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	1.69e-05	0.000117	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPIN1—chronic kidney failure	1.68e-05	0.000117	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCB1—chronic kidney failure	1.67e-05	0.000116	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PRKAG2—chronic kidney failure	1.66e-05	0.000115	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2B6—chronic kidney failure	1.66e-05	0.000115	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PRKD1—chronic kidney failure	1.66e-05	0.000115	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	1.65e-05	0.000115	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.65e-05	0.000114	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2C18—chronic kidney failure	1.65e-05	0.000114	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LRP2—chronic kidney failure	1.65e-05	0.000114	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	1.63e-05	0.000113	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—F2—chronic kidney failure	1.62e-05	0.000113	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LPL—chronic kidney failure	1.59e-05	0.00011	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.57e-05	0.000109	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SREBF2—chronic kidney failure	1.56e-05	0.000108	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACAT1—chronic kidney failure	1.55e-05	0.000107	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP1A1—chronic kidney failure	1.54e-05	0.000106	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	1.52e-05	0.000105	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	1.51e-05	0.000105	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCC3—chronic kidney failure	1.5e-05	0.000104	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCKR—chronic kidney failure	1.5e-05	0.000104	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPIN1—chronic kidney failure	1.47e-05	0.000102	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2C18—chronic kidney failure	1.44e-05	0.0001	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LRP2—chronic kidney failure	1.44e-05	0.0001	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	1.44e-05	9.97e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—chronic kidney failure	1.43e-05	9.93e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF1—chronic kidney failure	1.42e-05	9.86e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARA—chronic kidney failure	1.4e-05	9.74e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CPT1A—chronic kidney failure	1.4e-05	9.71e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.38e-05	9.54e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LIPC—chronic kidney failure	1.36e-05	9.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2C19—chronic kidney failure	1.36e-05	9.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SERPINE1—chronic kidney failure	1.35e-05	9.36e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.35e-05	9.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	1.32e-05	9.12e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—chronic kidney failure	1.29e-05	8.94e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SCARB1—chronic kidney failure	1.26e-05	8.74e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS1—chronic kidney failure	1.25e-05	8.65e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CPT1A—chronic kidney failure	1.23e-05	8.5e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SREBF1—chronic kidney failure	1.22e-05	8.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.22e-05	8.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.2e-05	8.3e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LIPC—chronic kidney failure	1.2e-05	8.29e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2C19—chronic kidney failure	1.2e-05	8.29e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMGCR—chronic kidney failure	1.19e-05	8.25e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.17e-05	8.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FASN—chronic kidney failure	1.16e-05	8.08e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.15e-05	7.97e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—POMC—chronic kidney failure	1.15e-05	7.94e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SCARB1—chronic kidney failure	1.1e-05	7.66e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS1—chronic kidney failure	1.09e-05	7.58e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP3A4—chronic kidney failure	1.08e-05	7.48e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.07e-05	7.44e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SREBF1—chronic kidney failure	1.07e-05	7.43e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCA1—chronic kidney failure	1.06e-05	7.36e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DDC—chronic kidney failure	1.06e-05	7.32e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—chronic kidney failure	1.04e-05	7.24e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMGCR—chronic kidney failure	1.04e-05	7.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.03e-05	7.11e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.03e-05	7.11e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.03e-05	7.11e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.02e-05	7.09e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FASN—chronic kidney failure	1.02e-05	7.08e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—chronic kidney failure	9.99e-06	6.92e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF2—chronic kidney failure	9.6e-06	6.65e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP3A4—chronic kidney failure	9.46e-06	6.56e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCA1—chronic kidney failure	9.3e-06	6.44e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—chronic kidney failure	9.29e-06	6.44e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCKR—chronic kidney failure	9.27e-06	6.43e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCC3—chronic kidney failure	9.27e-06	6.43e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—chronic kidney failure	9.13e-06	6.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPIN1—chronic kidney failure	9.07e-06	6.29e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAT—chronic kidney failure	8.98e-06	6.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	8.89e-06	6.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LRP2—chronic kidney failure	8.89e-06	6.16e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCB1—chronic kidney failure	8.74e-06	6.06e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—chronic kidney failure	8.53e-06	5.91e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPL—chronic kidney failure	8.33e-06	5.77e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP1A1—chronic kidney failure	8.04e-06	5.57e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—KRAS—chronic kidney failure	7.9e-06	5.48e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAT—chronic kidney failure	7.87e-06	5.46e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CPT1A—chronic kidney failure	7.56e-06	5.24e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—chronic kidney failure	7.5e-06	5.2e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LIPC—chronic kidney failure	7.36e-06	5.11e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	7.36e-06	5.11e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARA—chronic kidney failure	7.35e-06	5.1e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPL—chronic kidney failure	7.29e-06	5.06e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP1A1—chronic kidney failure	7.05e-06	4.88e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SCARB1—chronic kidney failure	6.8e-06	4.72e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS1—chronic kidney failure	6.74e-06	4.67e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF1—chronic kidney failure	6.61e-06	4.58e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—chronic kidney failure	6.57e-06	4.55e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARA—chronic kidney failure	6.44e-06	4.47e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMGCR—chronic kidney failure	6.43e-06	4.45e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FASN—chronic kidney failure	6.29e-06	4.36e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—POMC—chronic kidney failure	6e-06	4.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCA1—chronic kidney failure	5.73e-06	3.97e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—POMC—chronic kidney failure	5.25e-06	3.64e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—chronic kidney failure	5.23e-06	3.62e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAT—chronic kidney failure	4.85e-06	3.36e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—chronic kidney failure	4.79e-06	3.32e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—chronic kidney failure	4.78e-06	3.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCB1—chronic kidney failure	4.72e-06	3.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—chronic kidney failure	4.58e-06	3.18e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPL—chronic kidney failure	4.49e-06	3.12e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	4.34e-06	3.01e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—chronic kidney failure	4.19e-06	2.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—chronic kidney failure	4.05e-06	2.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARA—chronic kidney failure	3.97e-06	2.75e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—POMC—chronic kidney failure	3.24e-06	2.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—chronic kidney failure	2.95e-06	2.05e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—chronic kidney failure	2.82e-06	1.96e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—chronic kidney failure	2.58e-06	1.79e-05	CbGpPWpGaD
